If you have a commercial insurance plan, your VEOZAH prescription could be covered. Here’s how that might work:
WHAT YOU MAY
PAY FOR VEOZAHTM
Please see full Prescribing Information and Patient Information, including BOXED WARNING.
PRICE INFORMATION BELOW
The cost of VEOZAH (fezolinetant) may differ from person to person depending on insurance plans and other factors. We are committed to helping you understand your potential out‑of‑pocket (OOP) costs for VEOZAH.
You’ll find the following information on this site:
- The list price of VEOZAH
- Potential out‑of‑pocket cost with coverage
- Financial support programs that may be available to you
List Price
The price shown below is the list price that a patient without prescription insurance might pay for VEOZAH.
$566.00/month*
How much you will pay depends on your prescription insurance coverage.
Only your insurance company or pharmacy can tell you the exact amount you will pay. Please contact them for specific cost information.
The information above is based on a 30-day VEOZAH prescription
30-day prescription = A prescription written for 30 days at a time and refilled monthly
*AnalySource® Exported 1/13/25
The information provided here by Astellas is an estimate of probable costs. Such information may be subject to change. Patients should always check with their insurance provider for complete and accurate information about their specific out-of-pocket costs for VEOZAH.
We can help you figure out what you might pay for VEOZAH. Just choose one of the following:
Commercial
Insurance
You have prescription insurance through your employer or purchased directly by you
Example A
You pay a flat copay cost for every VEOZAH prescription.
Example B
You pay a deductible or co-insurance cost for each prescription, up to a maximum amount.
AVERAGE OUT‑OF‑POCKET (OOP) COST
The average OOP cost a patient with commercial prescription insurance would pay for VEOZAH:
$42/month**
How much you pay depends on your coverage. To find out the exact cost of your prescription, contact your commercial prescription insurance company.
The information above is based on a 30-day VEOZAH prescription
30-day prescription = A prescription written for 30 days at a time and refilled monthly
**Symphony Health, an ICON plc Company, PatientSource®, May 26, 2023 to January 3, 2025.
OOP Cost = The final cost that patient pays (post-secondary insurance and/or savings card)
VEOZAH Savings Program
You could get your first month's prescription at no cost, plus pay as little as $30 for future monthly prescriptions!*
- There are no income requirements
Click below to request, activate, or replace your VEOZAH Savings Card.
*ELIGIBILITY, RESTRICTIONS, AND TERMS AND CONDITIONS APPLY
Eligibility requirements and terms and conditions apply. Offer is not health insurance and is void where prohibited by law. A patient must have a valid prescription for VEOZAH, meet the eligibility requirements, and present the VEOZAH Savings Card to their preferred pharmacy. The program has an annual maximum copay assistance limit of up to [$4,000] per calendar year. Unless prohibited by law, Astellas may reduce the total copay assistance available under the Program to a maximum of [$1,250] for two months (i.e., two 28–31-day fills) if it determines a VEOZAH claim for an enrolled patient is not approved by their commercial health plan. There are no income requirements. This offer is not valid for cash-pay patients or patients whose prescription claims are reimbursed, in whole or in part, by any state or federal government program. Astellas reserves the right to revoke, rescind, or amend this offer at any time. For full terms and conditions, visit VEOZAHsavings.com.
Medicare Part D or Medicaid
You have prescription insurance through a government‑sponsored program
If you have Medicare Part D or Medicaid prescription insurance:
Medicare Part D
For each prescription, you either pay a deductible or co‑insurance cost. Once you have paid your deductible in full, the co‑insurance cost is a percentage as defined by your plan.
AVERAGE OUT‑OF‑POCKET (OOP) COST
The average OOP cost a patient with Medicare Part D prescription insurance would pay for VEOZAH:
$55/month**
Medicaid
AVERAGE OUT‑OF‑POCKET (OOP) COST
The average OOP cost a patient with Medicaid prescription insurance would pay for VEOZAH:
$2/month**
The information above is based on a 30-day VEOZAH prescription
30-day prescription = A prescription written for 30 days at a time and refilled monthly
**Symphony Health, an ICON plc Company, PatientSource®, May 26, 2023 to January 3, 2025.
OOP Cost = The final cost that patient pays (post-secondary insurance and/or savings card)
Uninsured
You don’t have prescription insurance, or your current prescription insurance doesn’t cover VEOZAH
If you are uninsured:
AVERAGE OUT‑OF‑POCKET (OOP) COST
The average OOP cost a patient without prescription insurance would pay for VEOZAH:
$566.00/month†
The Astellas Patient Assistance Program provides VEOZAH at no cost to patients who meet the program eligibility requirements.* All patients in this program who qualify receive their VEOZAH prescription at no cost.
Call 1-866-239-1637 1-866-239-1637 to see if you qualify.
*Subject to eligibility. Program terms and conditions apply. Void where prohibited by law.
The information above is based on a 30-day VEOZAH prescription
30-day prescription = A prescription written for 30 days at a time and refilled monthly
†AnalySource® Exported 1/13/25
OOP Cost = The final cost that patient pays (post-secondary insurance and/or savings card)
VEOZAH SUPPORT SOLUTIONS AWAITS YOU
To find out what resources and financial support options may be available, contact VEOZAH Support Solutions and speak with a dedicated access specialist who can help you:
- Find resources to help pay for VEOZAH, if eligible
- Answer your questions about insurance coverage and out‑of‑pocket costs
- Get additional information that may help
To learn more, call 1-866-239-1637 1-866-239-1637
Monday-Friday; 8 ᴀᴍ-8 ᴘᴍ (ET)
This website is intended for US residents only.
All trademarks are property of their respective owners. ©2025 Astellas Pharma
Inc. or its affiliates. MAT-US-VEO-2025-00503 06/25